8271
0
EMA Has Launched Its First Trial Of The Experimental Vaccine Against COVID-19
EMA has launched its first trial of the experimental vaccine against COVID-19, being developed by Oxford University and AstraZeneca.
Yazar: Tom Roberts
Yayınlanma: 5 Ekim 2020 06:50
Güncellenme: 22 Aralık 2024 12:30
EMA Has Launched Its First Trial Of The Experimental Vaccine Against COVID-19
The European Medicines Agency (EMA) has launched its first trial of the experimental vaccine against COVID-19, being developed by Oxford University and AstraZeneca. The Agency hopes that the process will speed up its eventual approval. The agency began analyzing preliminary information from scientists about the so-called Oxford vaccine, which suggests that it "triggers the production of antibodies and T-cells." According to the agency, it is waiting for data from the last stage of tests, which are attended by thousands of people, and agency hopes that they will share them in the coming months. They used a similar process to approve remdesivir, the only medicine approved for the treatment of COVID-19. She approved the drug after about a month, and the normal process takes almost seven months. During the final testing of the Oxford vaccine, one of the participants in the United Kingdom recently developed an adverse neurological reaction, for which the British suspended testing but had in the meantime resumed testing. In the United States, similar testing is suspended until the US Food and Drug Administration reviews the report of a side effect of the vaccine.İLGİLİ HABERLER
European stocks soared and focus shifted to German retail sales after Powell's speech!
Forex Signal For TRY/USD: Inflation Slowdown in November.
Forex Signal For GBP/USD: Bullish Trend Still Not Breaking While Recovery Continues.
Forex Signal For EUR/USD: Starry US Data Points to Higher Fed Increases.
Forex Signal For BTC/USD: Downside Continues as Bitcoin Recovery Moves Less.
En Popüler Haberler
Yorum Yap
Yorumlar
Henüz yorum yapan yok! İlk yorumu siz yapın...